• Event Times (GMT+10)
  • Local Times (GMT+2)
Posters
Poster Area
Monday, June 16, 10:15 AM – 10:45 AM
Poster Session 1: Schizophrenia
Therapeutic potential of brain-penetrating nanoparticles containing a selective VIP receptor 2 (VIPR2) antagonist peptide for schizophrenia
Maternal immune activation leads to schizophrenia-related behavioural and neurophysiological deficits in mothers and juvenile offspring
Effects of prenatal cannabinoids exposure: assessing the role of the endocannabinoid system in a neurodevelopmental animal model of psychopathology
Effect of GAD67 deletion in the thalamic reticular nucleus on sensory gating and sleep spindle activity
Effect of developmental deficits in ventral hippocampal excitatory and inhibitory neurons in schizophrenia-relevant phenotypes in mice
In vivo effects and molecular mechanism of a nanozyme-based artificial peroxisome on alleviating schizophrenia
Effects of antipsychotics and prenatal Poly I:C exposure on GSK3β-mediated signaling and NMDA/GABA receptors in the dorsal raphe nucleus of rats
Comparison of Brain age deviations among patients with schizophrenia, bipolar disorder, and major depressive disorder
Neuromelanin Accumulation and Treatment Responsiveness in Patients with Schizophrenia: A Cross-Sectional Study with Neuromelanin-Sensitive MRI
Genetic evidence for the association between schizophrenia and obesity
Validity of a smartphone application for self-monitoring psychiatric symptoms in patients with schizophrenia
Temporal Dynamics of Gut Fungi in Drug-Naïve First-Episode Schizophrenia Patients During Antipsychotics Treatment
Using minor physical anomalies to predict treatment resistance in schizophrenia patients through machine learning
Distinct and Common Subcortical Functional Connectivity Revealed Across Three Major Psychiatric Disorders
Incidence of psychosis and its risk factors and mortality in North Korean Defectors compared to South Korean controls
Screening of schizophrenia biomarkers based on proteomics and their application in early diagnosis
Impairment of the enhancement effect of perceived spatial separation on prepulse inhibition of Startle in first-episode Schizophrenia and clinical high risk for psychosis
Altered auditory network functional connectivity in psychotic disorder not other specified
Antipsychotic Medications and Risk Profiles Associated with Pneumonia in Patients with Schizophrenia Receiving Home-Care Case Management Intervention in Taiwan
Saliva versus Plasma Therapeutic Drug Monitoring of Clozapine and Norclozapine
Associations of polygenic risk scores differentiating attention-deficit hyperactivity disorder from autism spectrum disorder with cognitive and cortical alterations in schizophrenia patients
Structural brain differences in individuals at clinical high risk for psychosis
Leveraging white matter microstructural features to construct a high-performance diagnostic classifier for clinical high-risk for psychosis
Differences in the effects of antipsychotic drug-induced hyperprolactinemia in adolescent and adult schizophrenia patients: a retrospective pilot study
The effect of bright light therapy on symptoms and cognitive function in patients with schizophrenia
Medicinal cannabis an mental health hospitalisation: an observational study
Relationship between clozapine:norclozapine ratio and cognitive function and employment status in treatment resistant schizophrenia
The effect of sodium benzoate treatment for treatment resistant schizophrenia and its association with glutamate concentration: a pilot study with proton magnetic resonance spectroscopy
The association between cognitive inflexibility and decline deviation from fNIRS-measured brain function in schizophrenia
Distinct signatures of OSSOs compared to SSDs and HC using graph theory analysis
Effectiveness of long-acting injectable paliperidone palmitate on relapse prevention of schizophrenia
Retrospective study for correlation with reducing antiparkinsonian anticholinergic drugs and adverse effects
In vivo assessments of tau pathologies in patients with late-onset psychosis: a PET study
Obesity associated with symptomatic remission in clozapine-treated individuals with treatment resistant schizophrenia
A case of cryptococcal meningitis & Anti-NMDAR encephalitis in a patient with myelofibrosis in rural Victoria